Clinical Trials in New York

Showing 18981-19000 of 22,668 trials

Optimal Treatment for Kidney Disease in HIV Infected Adults

NCT00089518

The angiotensin receptor blocker (ARB) valsartan is a drug commonly used to treat high blood pressure. Valsartan may also help slow down the progression of kidney disease in HIV infected people. The purpose of this study is to compare valsartan and antiretroviral therapy (ART) to ART alone in slowing kidney disease progression in people with HIV.

HIV InfectionsKidney Disease

National Institute of Allergy and Infectious Diseases (NIAID)

Indianapolis, Indiana, United States • Indianapolis, Indiana, United States • Indianapolis, Indiana, United States +7 more locations

COMPLETEDPhase 3< 1 mile

S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

NCT00005866

RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells. It is not yet known if total-body irradiation plus peripheral stem cell transplantation is more effective with busulfan or with cyclophosphamide for myelodysplastic syndrome or acute myeloid leukemia. PURPOSE: Randomized phase III trial to compare the effectiveness of busulfan with that of cyclophosphamide in patients undergoing total-body irradiation plus peripheral stem cell transplantation for advanced myelodysplastic syndrome or related acute myeloid leukemia.

LeukemiaMyelodysplastic Syndromes

SWOG Cancer Research Network240 participantsStarted Feb 2000

Phoenix, Arizona, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +63 more locations

Optimal Treatment for Kidney Disease in HIV Infected Adults

S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

Find Trials by Condition in New York

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma

A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus

A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

Treatment for Non-Suicidal Self-Injury in Young Adults

Sonic Window Study Evaluation Plan

Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital

Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Immediate Implant Placement in the Esthetic Zone

MIND Score for Prolonged Mechanical Ventilation